GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Aprogen Medicines Inc (XKRX:007460) » Definitions » YoY EPS Growth

Aprogen Medicines (XKRX:007460) YoY EPS Growth : 173.78% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Aprogen Medicines YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Aprogen Medicines's YoY EPS Growth for the quarter that ended in Dec. 2023 was 173.78%.

Aprogen Medicines's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was ₩76.00.


Aprogen Medicines YoY EPS Growth Historical Data

The historical data trend for Aprogen Medicines's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprogen Medicines YoY EPS Growth Chart

Aprogen Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.50 -246.84 -97.45 69.37 52.52

Aprogen Medicines Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.82 75.17 87.13 36.02 173.78

Aprogen Medicines YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Aprogen Medicines's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(-236--497)/ | -497 |
=52.52 %

Aprogen Medicines's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EPS Growth (Q: Dec. 2023 )
=(Earnings per Share (Diluted) (Q: Dec. 2023 )-Earnings per Share (Diluted) (Q: Dec. 2022 )) / | Earnings per Share (Diluted) (Q: Dec. 2022 )) |
=(76--103.005)/ | -103.005 |
=173.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aprogen Medicines YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Aprogen Medicines's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Aprogen Medicines (XKRX:007460) Business Description

Traded in Other Exchanges
N/A
Address
545, Dunchon-daero, B1 Floor, Jungwon-gu, Sangdaewon-dong, Hallasigma valley,, Gyeonggi-do, Seongnam-si, KOR
Aprogen Medicines Inc, formerly Aprogen KIC Inc manufactures and maintains plant equipment for the industrial furnace and oven sector. Its business divisions include plant, fired heater, hard facing, and thermal insulation works.

Aprogen Medicines (XKRX:007460) Headlines

No Headlines